Hear from the Experts
To play any of the videos featured on this page, simply click on the links in yellow below.
Incidence of Body Acne
A Closer Look at Body Acne (James Q. Del Rosso, DO)
About Benzoyl Peroxide (BPO)
Advantages of Using Benzoyl Peroxide in the Treatment of Acne (Hilary Baldwin, MD)
Proven Comedolytic Activity (James Q. Del Rosso, DO)
Advantages of Leave-on vs. Wash Formulations (James Q. Del Rosso, DO)
Preventing BPO Bleaching (Hilary Baldwin, MD)
Advantages of Foam Formulation (ease of use)
Why Foams are Ideal for the Teenage Boy (Hilary Baldwin, MD)
Designed to Spread Farther, Easier (Diane Berson, MD)
Patients' Preference For Foam (James Q. Del Rosso, DO)
Well-Tolerated
Moisturization Reduces Dryness and Irritation (Diane Berson, MD)
Distinct Benefits for Dry Skin Patients (Diane Berson, MD / James Q. Del Rosso, DO)
Informative Videos for your Patients
Advantages of Leave-on vs. Wash Formulations (James Q. Del Rosso, DO)
Preventing Benzoyl Peroxide Bleaching of Fabrics (Hilary Baldwin, MD)
Moisturization Reduces Dryness and Irritation (Diane Berson, MD)
Featured dermatologists:
 |
Hilary Baldwin M.D., Associate Professor and Vice Chair Department of Dermatology State University of New York Brooklyn, NY |
 |
Diane Berson M.D., Assistant Clinical Professor of Dermatology Weill Medical College of Cornell New York, NY |
 |
James Q. Del Rosso, D.O., Dermatology Residency Director Valley Hospital Medical Center Las Vegas, NV |
Important Safety Information
BenzEFoam™ Emollient Foam should not be used on patients who have shown hypersensitivity to benzoyl peroxide or to any of the other ingredients in the product. Allergic contact dermatitis and dryness have been reported with topical benzoyl peroxide therapy. When using this product, avoid unnecessary sun exposure and use a sunscreen. BenzEFoam™ Emollient Foam, like all benzoyl peroxide containing products, may bleach hair or colored fabrics.
Please see full Prescribing information.
BenzEFoam™ Emollient Foam is indicated for use in the topical treatment of mild to moderate acne vulgaris
This site is published by Onset Therapeutics, which is solely responsible for its contents. This site intended for U.S. residents only.
Please see our Privacy Policy.
Site last updated: September 25, 2009.